发明名称 Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance
摘要 Compositions of hepatic therapeutic actives from one or more acridone compounds, one or more xanthone compounds, one or more thioxanthone compounds, one or more tocotrienol compounds, and one or more oleanolic triterpenoid compounds. Also, methods for treating various liver diseases or certain cancers with such hepatic therapeutic actives, as well as providing liver health maintenance.
申请公布号 US9498473(B2) 申请公布日期 2016.11.22
申请号 US201314093103 申请日期 2013.11.29
申请人 Heptiva LLC 发明人 Teow Vincent I.
分类号 A01N43/42;A61K31/44;A01N43/82;A61K31/41;A01N43/16;A61K31/35;A61K31/473;A61K31/355;A61K31/277;A61K31/352;A61K31/382 主分类号 A01N43/42
代理机构 Eric W. Guttag IP Law Office 代理人 Guttag Eric W.;Eric W. Guttag IP Law Office
主权项 1. A method of treating a liver disease selected from hepatitis B, hepatitis C, and hepatocellular carcinoma (HCC) in a human patient, comprising administering a hepatic therapeutic active comprising a Cratoxylum cochinchinense extract comprising, by weight of the hepatic therapeutic active: from about 28 to about 32% of one or more acridone compounds; from about 18 to about 22% of one or more xanthone compounds; from about 32 to about 42% of one or more thioxathone compounds; from about 3 to about 7% of one or more tocotrienol compounds; and from about 3 to about 7% of 3-hydroxy-23-sulfoxy-olean-12-en28-oic acid to a human patient in need thereof, a hepatic therapeutic amount of the hepatic therapeutic active, to treat the liver disease.
地址 Rutherford NJ US